Though the policymakers will be playing a straight bat here, saying a multi-lateral, co-ordinated approach is the only way, two top UK economists I've interviewed - one from the free market wing and one Keynesian - are remarkably close to saying it's time to forget worrying about protectionism, and for the mainstream to start responding to the demands for national solutions.
Today Biogen Idec (BIIB) reported top-line results of EMPOWER, a Phase 3 trial investigating dexpramipexole in people with amyotrophic lateral sclerosis (ALS).